罗浮山宫炎平品牌怎么样 申请店铺

我要投票 罗浮山宫炎平在女性洗液行业中的票数:104 更新时间:2025-01-22
罗浮山宫炎平是哪个国家的品牌?「罗浮山宫炎平」是 广东罗浮山国药股份有限公司 旗下著名品牌。该品牌发源于广东省惠州市,由创始人王 * 良在1970年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
罗浮山宫炎平怎么样

广东罗浮山国药股份有限公司,座落在广东罗浮山脚下,其前身——罗浮山药业始建于1970年,至今已有四十年发展史。公司投资上亿元按GMP标准建成了产、销一体的“罗浮山药业城”,占地面积10万多平方米、建筑面积8万平方米,至今已成为拥有员工近4000人、年纳税额超四千万元的大中型企业,是目前惠州市规模较大的制药企业,也是广东省内产能较大、剂型较齐全的中成药制剂企业之一。公司位于穗深经济走廊中心,旺盛的珠三角地域,毗邻港澳,交通四通八达,环境优雅。

罗浮山国药追求“以质量为本,科技创新”的经营理念,以继承和发扬具有1600多年历史的罗浮山中医药文化为已任,以造福百姓健康为宗旨,从事中西药品的开发、生产、销售以及中药材种植、生产加工和经营。四十年来,罗浮山国药不断挖掘和继承古代医药精华,利用当地丰富的中草药资源,系列颇具特色的品种、中药保护品种畅销国内外。公司现拥有的十一个剂型12条生产线全部通过国家GMP认证。年生产能力达片剂130亿片、颗粒剂3000吨、硬胶囊3亿粒、小容量注射剂2亿支、茶剂800万袋、搽剂8000万瓶、滴丸3亿粒、软胶囊2亿粒、栓剂5000万粒;提取车间年加工中药材可达2万吨,是广东省规模较大的中药提取车间之一。企业销售额每年以20-30%的幅度稳步增长。

朝气蓬勃的罗浮山国药已逐步发展壮大成为一个集科研、生产、销售和药材种植于一体的现代化高科技制药企业。随着企业不断发展壮大,坚信罗浮山国药将走在国内同行业的前列,屹立于中华药业之林。


Guangdong Luofushan Guoyao Co., Ltd. is located at the foot of Guangdong Luofushan. Its predecessor, Luofushan pharmaceutical industry, was founded in 1970 and has a history of 40 years. The company has invested more than 100 million yuan to build a "Luofushan pharmaceutical city" integrating production and marketing according to GMP standards, covering an area of more than 100000 square meters and a building area of 80000 square meters. So far, it has become a large and medium-sized enterprise with nearly 4000 employees and an annual tax payment of more than 40 million yuan. It is a large-scale pharmaceutical enterprise in Huizhou at present, and a Chinese patent medicine preparation with large production capacity and complete dosage forms in Guangdong Province One of the enterprises. The company is located in the center of suishen economic corridor, the exuberant Pearl River Delta region, adjacent to Hong Kong and Macao, with convenient transportation and elegant environment. Luofushan national medicine pursues the business philosophy of "quality-oriented, scientific and technological innovation", inherits and develops the culture of Luofushan Chinese medicine with a history of more than 1600 years, and aims to benefit the people's health. It is engaged in the development, production and sales of Chinese and Western medicine as well as the cultivation, production, processing and management of Chinese medicine. Over the past forty years, Luo Fu Shan has continuously excavated and inherited the essence of ancient medicine, and made use of the rich resources of Chinese herbal medicine, and a series of distinctive varieties and traditional Chinese medicine protection varieties have been sold well both at home and abroad. The company now has 11 dosage forms and 12 production lines, all of which have passed the national GMP certification. With an annual production capacity of 13 billion tablets, 3000 tons of granules, 300 million hard capsules, 200 million small volume injections, 8 million tea bags, 80 million bottles of liniments, 300 million drop pills, 200 million soft capsules and 50 million suppositories, the extraction workshop can process 20000 tons of traditional Chinese medicine annually, which is one of the large-scale TCM extraction workshops in Guangdong Province. The sales volume of the enterprise increases steadily by 20-30% every year. The vigorous Luofushan national medicine has gradually developed into a modern high-tech pharmaceutical enterprise integrating scientific research, production, sales and medicine planting. With the continuous development and growth of the enterprise, we firmly believe that Luofushan Guoyao will be in the forefront of the same industry in China and stand in the forest of Chinese pharmaceutical industry.

本文链接: https://brand.waitui.com/08d919ee4.html 联系电话:0752-6869068,6868938

千城特选小程序码

7×24h 快讯

五大险企去年保费收入近3万亿,净利或超预期改善

随着全年保费收入陆续发布,上市险企2024年业绩可见端倪。从负债端看,中国人寿、中国人保、中国平安、中国太保、新华保险等A股五大上市险企去年共实现原保险保费收入2.8万亿元,同比增长5.3%;从资产端来看,去年9月以来资本市场回暖,也带动保险投资收益获得正增长。在“资负”共振之下,较早推动寿险改革和投资稳健的大型险企,有望交出一份不错的年度答卷。(证券时报)

8分钟前

新加坡邮政任命Isaac Mah为集团首席财务官

根据新加坡交易所的一份文件,新加坡邮政任命Isaac Mah为集团首席财务官,自1月22日起生效。该公司已于12月披露了任命Mah担任首席财务官的意向。(界面)

8分钟前

香港上市制度优化成果显现,“巨无霸”与“小而美”共舞

2024年下半年以来,港股IPO市场持续复苏,呈现出一派新气象:不仅有美的、顺丰等A股巨头纷纷赴港上市,也有地平线、黑芝麻智能、毛戈平等各领域的头部企业登陆港股市场。不难发现,港股生态正在发生一场巨变:除开前几年的阿里、京东、美团等“巨无霸”登陆港股市场外,一些“小而美”并在自身领域独树一帜的各类企业也纷纷涌入,港股市场正在成为消费和科技前沿企业的聚集地。分析人士指出,港股生态的这一场巨变是2018年以来香港上市制度不断优化、进化结出的硕果。(证券时报)

8分钟前

Talpins的对冲基金向客户返还60亿美元,主要管理内部资本

Jeff Talpins的宏观交易对冲基金Element Capital Management去年返还了超过60亿美元资本,缩小了资产基础并向主要管理内部资金的方向迈进了一步。根据看到的一封致投资者信函,该公司在年底进行了第五次也是最后一次资本返还,将资产减至30亿美元。目前大约90%的资产是内部资金。此举是Element减少外部投资者计划的一部分。(新浪财经)

8分钟前

消息称巴菲特旗下Pilot退出国际石油交易业务

三名消息人士周二表示,巴菲特旗下的Pilot Co.将关闭其国际石油交易业务,结束进军这一万亿美元规模的全球市场的计划,重新专注于其在美国的Pilot Flying J加油站和卡车驿站业务。据两名知情人士透露,作为巴菲特旗下伯克希尔哈撒韦公司的子公司,Pilot已经裁掉了几乎所有负责国际贸易的员工。他们表示,该公司将把资源用于发展自己的北美业务,而不是贸易。Pilot没有就该公司是否退出国际贸易业务置评。(新浪财经)

8分钟前

本页详细列出关于西尼的品牌信息,含品牌所属公司介绍,西尼所处行业的品牌地位及优势。
咨询